Want to see JP:4694 full AI Analyst Report?
4694 Stock Chart & Stats
¥3815.00
-¥13.00(-0.45%)
At close: 4:00 PM EST
¥3815.00
-¥13.00(-0.45%)
Day’s Range― - ―
52-Week Range¥3,370.00 - ¥4,385.00
Previous CloseN/A
Volume47.40K
Average Volume (3M)54.09K
Market Cap
¥135.75B
Enterprise Value¥93.77K
Total Cash (Recent Filing)¥68.03B
Total Debt (Recent Filing)¥4.82B
Price to Earnings (P/E)17.9
Beta0.35
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.48%
Share Statistics
EPS (TTM)203.84
Shares Outstanding40,749,428
10 Day Avg. Volume38,460
30 Day Avg. Volume54,093
Financial Highlights & Ratios
PEG Ratio0.74
Price to Book (P/B)1.21
Price to Sales (P/S)1.02
P/FCF Ratio12.87
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥3,800.00Price Target Upside-0.39% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)222.3
Revenue Forecast (FY)¥157.00B
Bulls Say, Bears Say
Bulls Say
Strong Balance SheetVery low leverage and a large equity base provide durable financial flexibility. This solvency allows the company to fund R&D, capex or acquisitions, absorb cyclical shocks and avoid refinancing stress, supporting long-term stability and strategic optionality.
Improving Cash GenerationA rebound in operating and free cash flow after a trough indicates recovery in core cash generation. Sustained FCF supports dividends, reinvestment and debt avoidance, improving the company's ability to fund growth and return capital over the next several quarters.
Return To Revenue Growth & Positive MarginsResumption of revenue growth alongside positive gross and net margins signals restored demand and underlying profitability. If sustained, this trend enhances earnings stability, supports free cash flow expansion and validates the firm's competitive position in diagnostics.
Bears Say
Revenue & Margin VolatilitySignificant multi-year volatility in sales and margins reduces predictability of earnings and planning. Structural demand swings or competitive pressures that caused earlier declines could re-emerge, limiting visibility for investment decisions and long-term margin recovery.
Inconsistent Free Cash Flow ConversionWeak and inconsistent FCF conversion implies working capital swings or variable capex, undermining the reliability of cash available for dividends, buybacks or reinvestment. Persistent conversion shortfalls could force external financing or constrain strategic initiatives.
Lower Capital Efficiency (ROE Decline)A materially lower ROE versus prior peaks indicates diminished effectiveness in converting equity into profits. This reduced capital efficiency can limit shareholder value creation and suggests structural challenges in margins, pricing power, or asset utilization.
BML News
4694 FAQ
What was BML Inc’s price range in the past 12 months?
BML Inc lowest stock price was ¥3370.00 and its highest was ¥4385.00 in the past 12 months.
What is BML Inc’s market cap?
BML Inc’s market cap is ¥135.75B.
When is BML Inc’s upcoming earnings report date?
BML Inc’s upcoming earnings report date is Aug 07, 2026 which is in 15 days.
How were BML Inc’s earnings last quarter?
BML Inc released its earnings results on May 13, 2026. The company reported ¥32.07 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is BML Inc overvalued?
According to Wall Street analysts BML Inc’s price is currently Overvalued.
Does BML Inc pay dividends?
BML Inc pays a Semiannually dividend of ¥62.5 which represents an annual dividend yield of 3.48%. See more information on BML Inc dividends here
What is BML Inc’s EPS estimate?
BML Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BML Inc have?
BML Inc has 40,749,428 shares outstanding.
What happened to BML Inc’s price movement after its last earnings report?
BML Inc reported an EPS of ¥32.07 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.848%.
Which hedge fund is a major shareholder of BML Inc?
Currently, no hedge funds are holding shares in JP:4694
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BML Inc
BML, Inc. is a Japanese corporation specializing in a comprehensive range of laboratory diagnostics and related services. The company conducts standard analyses such as biochemical and hematological screenings, in addition to advanced specialized tests including radioimmunoassay (RIA), cellular diagnostics, immunology, and DNA analysis. It also provides microbiological assessments for medical and pharmaceutical organizations, along with diagnostic services covering critical areas like oncology, infectious diseases, metabolic disorders (diabetes, hypertension), allergies, and genetic studies. To optimize laboratory operations, BML develops proprietary automation systems, Frontier and Symphony, designed to streamline processes from initial sample sorting and dispensing through to subsequent testing. The firm also supports medical information networking via electronic health records and offers preventative healthcare solutions. BML's extensive service portfolio includes food safety and environmental health. Its food division provides comprehensive hygiene control and processing support, encompassing contractual microbiological testing for raw ingredients, prepared, and processed foods. This extends to environmental hygiene assessments for food facilities and kitchens, general microorganism testing, and the evaluation of genetically modified organisms. Environmental services comprise drinking water and wastewater analysis, occupational health management (measuring airborne substances like ethylene oxide, formaldehyde, organic solvents, and dust), comprehensive indoor environmental monitoring (identifying contaminants and other variables), and biological dioxin surveillance. Moreover, BML performs analyses for residual agricultural chemicals, offers dental diagnostics for caries and periodontal diseases, provides consulting for pharmaceutical product approvals, conducts investigative analyses for drug manufacturers, and performs gene expression analysis, specifically identifying genes linked to infectious disease susceptibility. Founded in 1955, BML, Inc. is headquartered in Tokyo, Japan.
4694 Stock 12 Month Forecast
Average Price Target
¥3,800.00
▼(-0.39% Downside)
Technical Analysis
PHC Holdings Corp.
―
Shin Nippon Biomedical Laboratories, Ltd.
―
Eiken Chemical Co., Ltd.
―
―
―






